Imaging Primer on Chimeric Antigen Receptor T-Cell Therapy for Radiologists

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL

(2021) Nirali N. Shah et al.   JOURNAL OF CLINICAL ONCOLOGY

‘Off-the-shelf’ allogeneic CAR T cells: development and challenges

(2020) S. Depil et al.   NATURE REVIEWS DRUG DISCOVERY

Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM)

(2020) Timothy J Kaufmann et al.   NEURO-ONCOLOGY

An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

(2020) Katharina Reinhard et al.   SCIENCE

Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy

(2020) Enrico Fritsche et al.   TRENDS IN BIOTECHNOLOGY

Emerging CAR Landscape for Cancer Immunotherapy

(2020) Francesca L.W.I. Lim et al.   BIOCHEMICAL PHARMACOLOGY

CARs: Beyond T Cells and T Cell-Derived Signaling Domains

(2020) Nico M. Sievers et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Management of Chimeric Antigen Receptor (CAR) T-Cell Toxicities: A Review and Guideline for Emergency Providers

(2020) Rishi Gupta et al.   JOURNAL OF EMERGENCY MEDICINE

Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer

(2020) Amy J. Petty et al.   Cancers

Toward Better Understanding and Management of CAR-T Cell–Associated Toxicity

(2020) Andrea Schmidts et al.   Annual Review of Medicine

Neurologic Toxicities of Cancer Immunotherapies: a Review

(2020) Rebecca A. Harrison et al.   Current Neurology and Neuroscience Reports

Companion vaccines for CAR T-cell therapy: applying basic immunology to enhance therapeutic efficacy

(2020) Adam E Snook   Future Medicinal Chemistry

A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity

(2020) Eleni Gavriilaki et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape

(2020) Alba Rodriguez-Garcia et al.   Frontiers in Immunology

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy.

(2020) M.-L. Schubert et al.   ANNALS OF ONCOLOGY

Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B cell malignancies

(2020) Jordan Gauthier et al.   BLOOD

All systems go: converging synthetic biology and combinatorial treatment for CAR-T cell therapy

(2020) Evripidis Lanitis et al.   CURRENT OPINION IN BIOTECHNOLOGY

Pseudoprogression of extramedullary disease in relapsed acute lymphoblastic leukemia after CAR T-cell therapy

(2020) Jie Huang et al.   Immunotherapy

Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies

(2020) Takayuki Ikezoe   INTERNATIONAL JOURNAL OF HEMATOLOGY

The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview

(2020) Niels Schaft   Cancers

Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy

(2020) Ahmed Hashim et al.   INFLAMMATORY BOWEL DISEASES

Cytokine Storm

(2020) David C. Fajgenbaum et al.   NEW ENGLAND JOURNAL OF MEDICINE

Acute respiratory distress syndrome

(2019) Michael A. Matthay et al.   Nature Reviews Disease Primers

Transfusion-associated circulatory overload and transfusion-related acute lung injury

(2019) John W. Semple et al.   BLOOD

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma

(2019) Jiasheng Wang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Chimeric Antigen Receptor T-Cell Therapy: What the Neuroradiologist Needs to Know

(2019) H.A. Valand et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Chimeric antigen receptor T cell persistence and memory cell formation

(2019) Alexander D McLellan et al.   IMMUNOLOGY AND CELL BIOLOGY

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia

(2019) Jing Pan et al.   LEUKEMIA

Multiple Myeloma Guidelines and Their Recent Updates: Implications for Imaging

(2019) Jennifer Mosebach et al.   ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN

Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy

(2019) Michael Byrne et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Tisagenlecleucel CAR-T Cell Therapy in Secondary CNS Lymphoma

(2019) Matthew J. Frigault et al.   BLOOD

Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome

(2019) Chelsea Kotch et al.   Expert Review of Clinical Immunology

Managing the toxicities of CAR T‐cell therapy

(2019) Sattva S. Neelapu   HEMATOLOGICAL ONCOLOGY

The CNS can be a safe space for CARs

(2019) Carlos Almeida Ramos   BLOOD

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)

(2019) Raza M. Alvi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Subcutaneous immunoglobulin replacement following CD19‐specific chimeric antigen receptor T‐cell therapy for B‐cell acute lymphoblastic leukemia in pediatric patients

(2019) Danielle E. Arnold et al.   PEDIATRIC BLOOD & CANCER

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

(2018) Jae H. Park et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL)

(2018) Bianca D. Santomasso et al.   Cancer Discovery

Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

(2018) Agne Taraseviciute et al.   Cancer Discovery

Cytokine release syndrome

(2018) Alexander Shimabukuro-Vornhagen et al.   Journal for ImmunoTherapy of Cancer

Tumor Lysis Syndrome

(2018) Shelly M. Williams et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells

(2018) Daniel W Lee et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Imaging in multiple myeloma: Which? When?

(2018) Elena Zamagni et al.   BLOOD

Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management

(2018) Jennifer N. Brudno et al.   BLOOD REVIEWS

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

(2017) Sattva S. Neelapu et al.   Nature Reviews Clinical Oncology

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

(2017) Sattva S. Neelapu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Imaging Spectrum of Invasive Fungal and Fungal-like Infections

(2017) Hilary L. P. Orlowski et al.   RADIOGRAPHICS

Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

(2017) Juliane Gust et al.   Cancer Discovery

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

(2014) Bruce D. Cheson et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

(2013) Cor HJ Lamers et al.   MOLECULAR THERAPY

Imaging of Acute Respiratory Distress Syndrome

(2012) S. Sheard et al.   Respiratory Care

Imaging of Pulmonary Viral Pneumonia

(2011) Tomás Franquet   RADIOLOGY

MRI of Cardiomyopathy

(2008) Elena Belloni et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

(2008) R A Kyle et al.   LEUKEMIA